Form 10-K for the Fiscal Year Ended December 31, 2022
You refer to various factors that impacted the declines in revenue here and in the segment discussion, including that revenue declines were due to the impact of several divested businesses, but do not quantify the impact of these factors. Where a material change is due to two or more factors, please revise to provide a quantified discussion of the factors impacting revenue.Rest of the question
Similar concerns apply to your discussion of expenses on page 42. Refer to Item 303(b) of Regulation S-K.
The Company confirms that in future filings, including the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, when a material change is due to two or more factors the Company will provide a quantified discussion of the factors impacting revenue and expenses in accordance with Item 303(b) of Regulation S-K.Read in the reply
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note you present total Adjusted EBITDA. Please revise to reconcile this non-GAAP measure to net income (loss), the most directly comparable GAAP measure, similar to your reconciliation of Adjusted EBITDA on page 17 in Exhibit 99.1 of the Form 8-K furnished on February 7, 2023.Rest of the question
Further, “Total segment EBITDA” and “Operations and Other EBITDA” are non-GAAP measures and should also be reconciled to the most directly comparable GAAP measure, net income. However, once reconciled it would appear such measures may include adjustments that are inconsistent with the applicable non-GAAP guidance. Therefore, you should consider removing these measures as you do not appear to incorporate them in your results discussion. Refer to Item 10(e)(1)(i)(B) of Regulation S-K and Questions 100.01 and 104.04 of the Non-GAAP C&DIs. Consolidated Financial Statements (3) Goodwill, Customer Relationships and Other Intangible Assets, page 83
The Company confirms that in future filings, beginning with the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, the Company will reconcile the segment’s designated measure of profit or loss, Segment adjusted EBITDA, to the Company’s net income (loss), the most directly comparable GAAP measure. The Company will also remove references to “Total segment EBITDA” and “Operations and Other EBITDA” from its disclosure as previously presented in prior MD&A reconciliation tables.Read in the replyRest of the answer
To reconcile the measures of profit or loss to the Company’s net income (loss), amounts previously included in “Operations and Other EBITDA” will now be included as “Other unallocated amounts” to comply with Regulation G. The reconciliation will be substantially similar to the presentation shown on Appendix 1 to this letter, which is comparable to the reconciliation previously included on page 17 of the Company’s February 8-K.
Consolidated Financial Statements
(3) Goodwill, Customer Relationships and Other Intangible Assets, page 83
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note that the indicated control premium was approximately 59% as of the October 31, 2022 goodwill impairment test. Please provide us with a comprehensive analysis of how you determined the control premium and how you concluded that it was reasonable.
As of October 31, 2022, the Company estimated the fair value of its four reporting units by considering both a market approach and a discounted cash flow method. For the market approach, the Company reviewed its position amongst its peer groups and analyzed multiples for completed transactions and equity premiums by region.Read in the replyRest of the answer
The Company selected revenue and Adjusted EBITDA multiples comparable to the multiples of its (i) divestiture of its Latin American business on August 1, 2022 (approximately 9x Adjusted EBITDA), (ii) divestiture of its 20-state ILEC business on October 3, 2022 (approximately 5.5x Adjusted EBITDA) and (iii) announced EMEA divestiture on November 2, 2022 (approximately 11x Adjusted EBITDA). Consistent with prior goodwill impairment assessments, management reviewed the Company’s selected market multiples to its seven peer companies. The Company’s peer group consists of public companies in the communications sector that generally have similar focus, product offerings and relative size. The Company’s peer group has remained relatively consistent and also includes five companies listed in the Compensation Benchmarking and TSR Peer Groups on page 77 of the Company’s 2022 Proxy Statement. Based upon this analysis and review, management concluded its multiples were reasonable as they were within the range of the peer group multiples and consistent with closed and announced divestitures. For the discounted cash flow (“DCF”) method, a DCF analysis was performed using the latest forecast reviewed by the Company’s Board of Directors. The Company calculated and compared revenue and Adjusted EBITDA growth and unlevered cash flow growth as well as Adjusted EBITDA margin profiles. The long-term growth rates used were in line or below (given perpetuity considerations) comparable average growth for revenue, Adjusted EBITDA and unlevered cash flow in future years based on the Company’s long-term forecast. The weighted cost of capital (“WACC”) was determined using a market participant approach. The market participant approach WACC was built using the Company’s cost of debt and equity with an additional 5% company specific equity risk premium to reflect risk in the Company’s forecast. Management considered this approach consistent with how a purchaser (market participant) would develop a WACC to discount cash flows to address execution and market risk. Management considered macro level, sector and internal drivers when forecasting the expected performance of reporting units and geographies, as well as internal company strategy, operational and execution risk. Consistent with prior years, management prepared the Company’s goodwill impairment test utilizing the forecast reviewed by the Company’s Board of Directors, market multiple ranges of the selected peer companies and ranges of indicated control premiums from historical transactions. Considering all of these factors, management concluded the selected WACC, market multiples, long-term growth rate estimated fair value and indicated control premium were all reasonable.
Management reconciled the estimated fair values of the reporting units to the Company’s market capitalization as of October 31, 2022, and concluded the indicated control premium of approximately 59% was reasonable based on a range of control premiums from recent market transactions discussed below and the valuations from the Company’s recently closed and announced divestitures referenced above. The Company’s market capitalization, when compared to the fair value of equity of its reporting units calculated in accordance with GAAP, was the primary driver of its 59% indicated control premium. Peer analysis and review at the time of the assessment provided additional context to management that the Company’s market capitalization was depressed, and the overall company was undervalued compared to competitors with similar assets, customers, and business models. Based upon 78 closed and announced transactions in the Telecommunication Services industry in the United States, Canada, Europe, Asia Pacific, Africa and Middle East for the period November 1, 2017 to October 31, 2022, the target stock premiums one day prior to the deal announcement ranged from 0.0% to 92.9%. Narrowing the transaction period to November 1, 2021 to October 31, 2022, the target stock premium one day prior to the deal announcements for eleven transactions ranged from 1.3% to 71.6%. Based upon these factors, management determined the Company’s indicated control premium of 59% was within the range for the selected comparable transactions.
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Please tell us the fair value and carrying value of each reporting unit as well as the goodwill allocated to each reporting unit as of October 31, 2022. Also, provide us with your reconciliation of the estimated fair value of your reporting units to the company’s market capitalization as of October 31, 2022.
Reporting Units as October 31, 2022Read in the reply
(in millions) Mass Markets NA Business APAC EMEA Total
Concluded Fair Value of Equity $2,632 $7,428 $340 $1,723 $12,123
Carrying Value of Equity $1,337 $10,656 $170 $635 $12,797
Allocated Goodwill $4,752 $11,126 $0 $51 $15,928
Indicated Control Premium Analysis
(in millions except Share Price) October 31, 2022
Concluded Fair Value of Equity of Reporting Units $12,123
Share Price as of October 31, 2022 $7.36
Multiplied by Shares outstanding 1,035
Market capitalization $7,615
Indicated control premium (discount) 59.2%
In addition, during 2022, theRest of the answer
Company also impaired $43 million goodwill on a business classified as held for sale, which is included in the $3,271 million ($3,228 million + $43 million) goodwill impairment disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note that there has been a significant decline in your market capitalization since the October 31, 2022 goodwill impairment test was performed and since your December 31, 2022 year end. It appears that this may be a triggering event that would require you to reassess your goodwill for impairment.Rest of the question
Please tell us what consideration you have given to reassessing the recoverability of your goodwill in the first quarter of fiscal 2023. If you did not perform impairment tests during the first quarter, please explain why. To the extent that an impairment test was performed, tell us whether or not an impairment of goodwill existed. Refer to ASC 350-20-35-30. (4) Revenue Recognition
As of December 31, 2022 and up to the issuance of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, management considered the decline in the market capitalization after the announcement to eliminate the Company’s dividend and determined that it did not change the Company’s assumptions and conclusions with regards to the fair value of the remaining reporting units as of December 31, 2022.Read in the replyRest of the answer
Additionally, the sale of the Latin American business on August 1, 2022 (at a price approximately 9x Adjusted EBITDA), the sale of the 20-state ILEC business on October 3, 2022 (at a price approximately 5.5x Adjusted EBITDA) and the proposed EMEA business divestiture announced on November 2, 2022 (at a price approximately 11x Adjusted EBITDA), all had purchase multiples consistent with those used in the Company’s most recent goodwill impairment tests as of October 31, 2022. These transactions support the position that the Company’s market capitalization during the first quarter of 2023 did not directly correlate with the fair value of equity of the Company’s reporting units calculated in accordance with GAAP (as discussed in the Company’s prior responses above).
During the first quarter of 2023, management (i) assessed the following qualitative factors, (ii) made the determinations summarized below and (iii) determined it was not more likely than not that the fair values of the Company’s reporting units were less than their carrying amount, including goodwill.
•No adverse changes in macroeconomic conditions
◦There were no significant adverse changes, consistent with the disclosures the Company plans to make in its earnings release scheduled for May 2, 2023 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023. Additionally, as discussed in response 3 above, we included a 5% company specific equity risk premium at October 31, 2022. As our terminal year forecast did not significantly change and the yield on the 10-year US Treasury Bond declined 62 basis points since October 31, 2022, we considered this risk premium to be adequate to cover the forecast risk at March 31, 2023.
•No changes in industry and market conditions
◦There were no significant adverse changes, consistent with the disclosures the Company plans to make in its earnings release scheduled for May 2, 2023 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.
•No changes in cost factors that would have a negative impact on cash flows
◦Inflationary pressures were considered by management for the Company’s October 31, 2022 goodwill impairment assessment, and no significant changes since October 31, 2022 were noted.
•No changes in overall financial performance
◦Management compared the forecast used for the October 31, 2022 goodwill impairment test to the Company’s most recent forecast and noted no significant changes to the long-term forecast and growth rates.
◦Management compared year-to-date first quarter 2023 results to the most recent forecast and did not identify any significant underperformance against the October 31, 2022 forecast.
•No changes in management, strategy, and customers
◦During the Company’s Q4 2022 earnings call on February 7, 2023, members of the Company’s executive team discussed strategic plans for a return to growth. These strategic plans were considered during the Company’s October 31, 2022 goodwill impairment assessment. For the Company’s Mass Markets segment, management is forecasting a high level of capital investment in connection with its Quantum Fiber buildout plans, which will decrease near term cash flow but is expected to improve the Company’s cash flows beyond five years and the Company’s terminal value. For the Company’s Business segment, management is making material capital investments to expand the Company’s ability to service customers in key metropolitan markets. These changes in strategic direction will result in a reduction in revenue and increase in expenses in the short-term but are designed to position the Company for future growth. The Company determined that its terminal year cash flows were not materially impacted by the strategic reset and, therefore, management concluded there was not a trigger for further impairment assessment.
◦During the first quarter of 2023, we implemented senior leadership management changes to align with the previously announced strategic plans and these were considered during our October 31, 2022 goodwill impairment assessment. Management concluded these changes did not trigger the need for further impairment assessment.
•No events affecting a reporting unit
◦Management determined there were no changes affecting reporting units which were aligned with the Company’s strategic plans and considered in the Company’s October 31, 2022 goodwill impairment test.
•No significant company specific adverse events that would potentially cause a sustained decrease in our share price
◦On February 7, 2023, the Company announced guidance for Adjusted EBITDA, capital expenditures and free cash flow for 2023 that was lower than investors were expecting. The Company determined that this contributed to an additional decline in the Company’s market capitalization during Q1 2023. Nonetheless, the Company determined during the first quarter of 2023 that its terminal year cash flows had not been materially impacted by the Company’s strategic plans to focus on making growth investments in the business.
As referenced in ASC 350-20-35-3D, we assessed the totality of events and circumstances including those above and determined the share price decline was a potential impairment trigger, but in the context of the other facts and circumstances described above, did not ultimately result in a conclusion there was an impairment triggering event to perform a quantitative impairment test during the first quarter of 2023. The Company plans to include additional cautionary language in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 related to the potential risk for an impairment triggering event in future quarters if there are sustained share price declines, revisions to the Company’s long-range strategic plans, underperformance against those plans, or similar adverse developments.
(4) Revenue Recognition
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
You disclose you expect to recognize approximately 75% of the $7.4 billion in revenue related to performance obligations associated with existing customer contracts that are partially or wholly unsatisfied through 2025, with the balance recognized thereafter.Rest of the question
Please revise to better describe when such revenue will be recognized using time bands that would be most appropriate for the duration of the remaining performance obligations or by using qualitative information. In this regard, explain how the 75% will be recognized through 2025, (e.g. ratably), or indicate the percentage estimated to be recognized each year. Refer to ASC 606-10-50-13b. (17) Segment Information, page 131
The Company confirms that in future filings, including the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, the Company will provide disclosure similar to the following:Read in the reply
“As of March 31, 2023, we expect to recognize approximately $X.X billion of revenue in the future related to performance obligations associated with the existing customer contracts that are partially or wholly unsatisfied.Rest of the answer
As of March 31, 2023, the transaction price related to unsatisfied performance obligations that are expected to be recognized for the remainder of 2023, 2024 and thereafter was $X.X billion, $X.X billion and $X.X billion, respectively.”
Management believes this disclosure is more aligned with peers in the Company’s industry sector and is responsive to the Staff’s comment by providing the users of the financial statements with additional information as to the amount and timing as well as trends relating to the amounts and expected timing of revenue to be recognized from the remaining performance obligations.
(17) Segment Information, page 131
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note your segment results presentation includes adjusted EBITDA for “Operations and Other” and Total adjusted EBITDA. Please revise to remove these columns as these are non-GAAP measures and should not be included in the Notes to the financial statements. Refer to Item 10(e)(1)(ii)(C) of Regulation S-K. (18) Commitments, Contingencies and Other Items, page 133
The Company confirms that in future filings, including the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, the Company will remove columns for “Total Segments,” “Operations and Other,” and “Total Adjusted EBITDA.” Consistent with the Company’s response above to Comment 2, the Company plans to add a reconciliation table that includes an adjustment for “Other unallocated amounts.” See Appendix 2 to this letter.Read in the replyRest of the answer
The Company believes the inclusion of this adjustment for “Other unallocated amounts” is required for the Company to reconcile its reportable segments’ measure of profit or loss, Segment adjusted EBITDA, to the Company’s most directly comparable GAAP measure, consolidated net income (loss), and the reconciliation of the Company’s reportable segments’ amounts for other significant items to the corresponding consolidated amount, as required by ASC 280-10-50-30 and shown in illustrative example ASC 280-10-55-49.
(18) Commitments, Contingencies and Other Items, page 133
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
You disclose that as of any given date you could have exposure to losses under proceedings as to which no liability has been accrued or as to which the accrued liability is inadequate. Please revise to clarify for all matters whether you believe there at least a reasonable possibility that a loss may have been incurred or incurred in excess of amounts already accrued and if so, disclose an estimate of such loss or aRest of the question
range of loss or state that such estimate of possible losses cannot be made. Refer to ASC 450-20-50-4.
With respect to the paragraph cited by the Staff in this comment, the Company plans in future filings to make the modifications noted below:Read in the reply
“We review our litigation accrual liabilities on a quarterly basis, but in accordance with applicable accounting guidelines only establish accrual liabilities when losses are deemed probable and reasonably estimable and only revise previously established accrual liabilities when warranted by changes in circumstances, in each case based on then-available information.Rest of the answer
As such, as of any given date we could have exposure to losses under proceedings as to which no liability has been accrued or as to which the accrued liability is inadequate. Subject to these limitations, at March 31, 2023, we had accrued $XX million in the aggregate for our litigation and non-income tax contingencies, which is included in other current liabilities, other liabilities, or liabilities held for sale in our consolidated balance sheet as of such date. We cannot at this time estimate the reasonably possible loss or range of loss in excess of this $XX million accrual due to the inherent uncertainties and speculative nature of contested proceedings. The establishment of an accrual does not mean that actual funds have been set aside to satisfy a given contingency. Thus, the resolution of a particular contingency for the amount accrued could have no effect on our results of operations but nonetheless could have an adverse effect on our cash flows.”
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note your Modified Metrics exclude the financial impacts of divested businesses and the lapsed CAF Phase II program, and includes estimates of revenue you would have received under post-closing agreements. These adjustments result in individually tailored recognition and measurement principles that are inconsistent with GAAP since the divested businesses did not meet the criteria for presentation as aRest of the question
discontinued operation pursuant to ASC 205-20 and the lapsed program was included in your continuing operations. We also note that you include an estimate of revenue for which you did not earn in the periods presented. Please revise to remove these measures and references throughout. Refer to Question 100.04 of the non-GAAP C&DIs. Similar concerns apply to the Form 8-K furnished on January 27, 2023 and the earnings release and tables, trending schedule, and presentations included on your website.
The Company acknowledges the Staff’s comment and respectfully advises the Staff that the Company has reviewed Question 100.04 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations. During our call with Ms. Melissa Kindelan and Ms. Christina Dietz of the Staff at 12 pm MST on April 20, 2023, the Company outlined its rationales for furnishing the Modified Metrics1 and advised the Staff of its intent to comply with Comment No.Read in the replyRest of the answer
9 above by revising its presentation to remove these measures and references throughout its future filings, beginning with its March 31, 2023 Form 10-Q, Form 8-K Item 2.01, earnings release and tables, trending schedule, and related presentations included on its website. Specifically, the Company will report its financial results and related non-GAAP measures without the modifications referenced in the Staff comment, by including footnotes to such results clarifying that reported amounts: (i) include quantified amounts associated with the prior operations of the Latin American business divestiture completed August 1, 2022 and the 20-state ILEC business divestiture completed October 3, 2022, (ii) include the financial impacts of the Federal Communications Commission's Connect America Fund ("CAF") Phase II program, which lapsed on December 31, 2021, and (iii) do not include estimates of amounts received or paid by the Company under the post-closing agreements with the purchasers of the divested businesses.
To implement these changes, the Company proposes to include the footnote disclosure on a prospective basis similar to the following when presented in its earnings release and tables, trending schedule, and related presentations included on the Company’s website:
•The financial impacts related to the Latin American business divestiture completed August 1, 2022 and the 20-state ILEC business divestiture completed October 3, 2022 (the “divestitures”) include revenue of $XX and $XX, adjusted EBITDA excluding Special Items of $XX and $XX, and Adjusted EBITDA margin, excluding Special Items of $XX and $XX, which will not recur in periods following the completion of these divestitures. The Company believes that these figures will allow analysts and investors to understand the amounts associated with these transactions to understand the impact they had on the Company's past, but not current or future, financial performance. Therefore, these amounts will impact the Company’s ability to match its past performance in current and future periods.
•The financial impacts of the Federal Communications Commission's Connect America Fund ("CAF") Phase II program, which lapsed on December 31, 2021, are $XX. The Company believes that this provides useful information to investors to understand the impact that the CAF Phase II program had on the Company's revenue generating activities in relation to the Company’s past, but not current or future, financial performance.
•The post-closing financial impacts of actual amounts received or paid by the Company under the post-closing agreements with the purchasers of the divested businesses were $XX. The Company believes that this provides useful information to investors to understand the impact that the post-closing agreements have had on the Company's activities and its current financial performance.
Further, the Company advises the Staff that any time the Company discloses a non-GAAP measure it will comply with all applicable requirements under Regulation G, including ensuring to (i) include a presentation of the nearest GAAP measure with equal or greater prominence (to the extent applicable) (ii) provide a reconciliation from the nearest GAAP measure to the non-GAAP measure, (iii) clearly label the measure as non-GAAP, (iv) include a statement disclosing the reasons why management believes the presentation of the non-GAAP measure provides useful information to investors, and (v) provide additional information as to amounts included in GAAP results in a supplemental format to allow investors to understand the impacts on trends which would impact financial performance.
1For further information, see the Company’s response to Comment No. 11 below.
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note that you present several non-GAAP measures in this table before the most directly comparable GAAP measure. Please revise to provide the comparable GAAP measure before the non-GAAP measures. You also present adjusted EBITDA margin and adjusted EBITDA margin, excluding special items here and on page 17 but do not present the comparable GAAP margin measure.Rest of the question
Please revise to present net income (loss) margin with equal or greater prominence. Refer to Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10(a) of the Non-GAAP C&DIs.
The Company confirms that in future filings, including the Company’s Q1 2023 earnings release, the Company will provide the comparable GAAP measure, Operating Income (Loss) and Operating Income (Loss) Margin, before Adjusted EBITDA and Adjusted EBITDA margin in the recurring Financial Results table. Please see Appendix 3 to this letter. The Company believes this will present the comparable GAAP measures with greater prominence than the non-GAAP measures.Read in the reply
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
This presentation includes “as reported” non-GAAP adjusted EBITDA excluding special items and adjusted EBITDA margin excluding special items, without the comparable GAAP measures and reconciliations to the most directly comparable GAAP measure. Please revise to include the comparable GAAP measures and reconciliations for the “as reported” non-GAAP measures. Refer to Item 100(a) of Regulation G.Rest of the question
We also note several non-GAAP measures are further adjusted and labeled “as modified.” As noted in comment 9 above, these modified measures result in individually tailored recognition and measurement principles that are inconsistent with GAAP. Please revise to remove the “as modified” measures. Refer to Question 100.04 of the non-GAAP C&DIs. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
The Company believes that the January 8-K explained the relationship between GAAP figures and the Company’s supplemental historical financial information contained in such report. The Company also believes its February 8-K further explained the non-GAAP nature of its January 8-K disclosures by including the following three statements:Read in the reply
•A statement in Footnote 1 on page 1 labelling its Modified Metrics as non-GAAP financial measures, and directing investors to the most directly comparable GAAP measures located on the Company’s website
•A statement on page 14, under the heading “DescriptionRest of the answer
of Non-GAAP Metrics,” that directed investors to further detailed information regarding its Modified Metrics
•Footnote 1 to the table on page 17 directing investors to additional information on the Company’s non-GAAP special items.
The Company always intended its January 8-K modified measures to be a one-time disclosure of supplemental historical financial information to aid investors prior to the Company’s release of earnings less than two weeks later. The Company believes its Modified Metrics did not mislead investors2 but instead had the opposite effect of enhancing their understanding of the Company’s recent performance and providing them with the ability to compare the Company’s post-divestiture performance to its past performance. The Company believes the disclosures contained in its January 8-K, coupled with those in its February 8-K, enabled investors to clearly understand the relationship between the Company’s GAAP and supplemental figures. As such, the Company believes amending the January 8-K would cause undue confusion to investors.
2The Company notes that Regulation G is “intended to ensure that investors and others are not misled by the use of non-GAAP financial measures (SEC Release No. 33-8145 (Nov. 4, 2002), 67 FR 68490).
In light of the foregoing, along with the Company’s agreement in its response to Comment 9 herein to prospectively modify its reporting, the Company respectfully believes that it is in the best interests of investors and shareholders to refrain from amending the January 8-K.
The Company acknowledges that the Company and its management are responsible for the accuracy and adequacy of the disclosure, notwithstanding any review, comments, action, or absence of action by the Staff. The Company qualifies each of its forward-looking statements contained in this letter by reference to the qualifying factors and risk factor disclosures contained in its filings with the SEC.
First report after the company's reply of Apr 25, 2023: 10-Q filed May 2, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note in your response to prior comment 3 that you used a market approach and a discounted cash flow method. Please tell us how each was weighted in estimating the fair value of the reporting units.
The Company utilized the following weighting for the market approach and discounted cash flow method for each of our reporting units in estimating the fair value of each reporting unit as of October 31, 2022:Read in the reply
Weighting
Reporting Unit Market Approach Value Income Approach Value
NA Business 50% 50%
Mass Markets 50% 50%
EMEA 80% 20%
APAC 80% 20%
As noted above, to estimate the fair value of our NA Business and Mass Markets reporting units, we used a 50/50 weighting between the discounted cash flow method (“DCF” or “Income Approach”) and market approach.Rest of the answer
Management reviewed different weightings and determined that a 50/50 weighting on DCF and market approach was the most appropriate at October 31, 2022. In doing so, we considered models used by financial analysts and other third parties to value Lumen, as well as prices offered by third party bidders to purchase portions of our business. As of December 31, 2022, there was no goodwill allocated to the EMEA and APAC reporting units.
With regards to your market approach, please describe the trends in your NA Business revenue and EBITDA multiples over the last several years. Also, you disclose on page 50 that you performed sensitivity analyses that considered a range of discount rates and EBITDA market multiples.Rest of the question
Tell us whether you performed a sensitivity analysis of the NA Business revenue and NA Business EBITDA multiples and, if so, please provide. Lastly, in your response to prior comment 3, you indicate that your multiples were within the range of the peer group multiples. Please provide us with the range of the peer group multiples and tell us where the NA Business fell within the range.
In connection with estimating the market approach value of our NA Business reporting unit, we utilized the following revenue and EBITDA multiples for quantitative assessments performed during the following periods beginning March 31, 2019 and ending October 31, 2022.Read in the reply
10/31/22 10/31/21
1/31/21(1)
10/31/20(1)
10/31/19(1)
3/31/19(2)
NA Business Revenue Multiple 2.0 2.5 2.2 2.2 2.2 2.0
NA Business EBITDA Multiple 5.0 6.6 6.0 5.9 5.9 5.5
(1) As previously disclosed, we made changes to our segment and customer-facing sales channel reporting categories in early 2021 to align with operationalRest of the answer
changes designed to better support our customers. Therefore, the NA Business revenue multiples and EBITDA multiples were calculated using a weighted average of our previous reporting units in this trend analysis.
(2) Because our low share price was a trigger for impairment testing, we estimated the fair value of our operations using only the market approach.
As of October 31, 2022, we performed concurrent sensitivity analyses to test the impact of various revenue and EBITDA multiple combinations for the NA Business reporting unit. These sensitivity analyses considered revenue and EBITDA multiple ranges of our peer group as shown in the table below. We historically utilized these peer group comparisons as part of our assessment of potential market participants, as our peers are in similar industries and provide a reasonable range for market-based measurements of fair value. In addition, we examined the impacts of various revenue and EBITDA multiple combinations in relation to:
•Historical NA Business multiples and implied valuations
•The spread between the revenue and EBITDA multiples’ implied valuations
•Impact on fair value of invested capital and excess/deficit to the carrying value of equity
•Impact of the NA Business reporting unit valuation to Lumen’s overall implied control premium
Generally, we have historically performed a similar analysis as part of every goodwill impairment assessment we have conducted in recent years to ensure all relevant factors are considered when selecting the Market Multiples and Long-term Growth Rates (“LTGR”) for our reporting units. We calculate and compare revenue growth, EBITDA, and Unlevered Cash Flow growth as well as EBITDA margin profiles. We generally assume that periods of growth or declines will normalize over time and moderate beyond the forecast horizon. We also consider how cost efficiencies and strategic investments made in the near term will impact our future financial performance. We additionally considered any changes in go-to-market strategies, sales channels, leadership changes and product categories (including our recent change to “grow/nurture/harvest/other” product categories) for each reporting unit. We also considered at October 31, 2022 the areas where initiatives would have the greatest impact while remaining mindful of each reporting unit’s respective strategic position, the overall macroeconomic environment, and related recessionary concerns.
At October 31, 2022, we reduced our NA Business revenue and EBITDA multiples from prior year multiples to align with the lower margins and lower revenue expectations used to set our earnings guidance for 2023. We expect to see the largest uplift from our targeted initiatives in this reporting unit. Key strategic priorities include promoting our Edge, Network-as-a-Service, Unified Communications & Collaboration, and Security and Secure Access Service Edge products, supported by higher sales from the digital portal and overall enterprise transformation and simplification efforts. As we have discussed in our previous reports, however, we do not expect these initiatives to result in revenue or EBITDA growth until 2025, which we believe supports using the below-market multiples.
The range of peer group 2022 revenue and EBITDA multiples and selected multiples utilized for NA Business are provided in the table below. NA Business’ multiples were substantially below the average peer group revenue and EBITDA multiples.
You disclose the weighted average cost of capital (WACC) used for the NA Business reporting unit was 9.4% and you indicate in your response that this included a 5% company specific equity risk premium. Please tell us whether you included a company specific equity risk premium in the WACC assumption in prior quantitative analyses and, if not, why such premium was included in the 2022 analysis.
The Company assesses its specific debt and equity risk premium when determining the overall WACC. We have included a company specific equity risk premium in prior quantitative analyses. Additionally, we consider a company specific debt risk premium based on the trading levels of the Company’s debt and access to capital markets. The increase in our company specific equity risk premium is primarily tied to the volatility and trending of our share price.Read in the replyRest of the answer
The following table provides our company specific risk premium (equity and debt) for prior quantitative analysis.
Oct-22 Oct-21 Jan-21 Oct-20 Oct-19
Mar-19(1)
Company Specific Risk Premium 5.0% 5.0% 2.0% 4.0% 0.0% N/A
(1) Because our low share price was a trigger for impairment testing, we estimated the fair value of our operations using only the market approach.
In your response you indicate that you compared revenue, Adjusted EBITDA growth and unlevered cash flow growth, as well as Adjusted EBITDA margin profiles and that the long-term growth rates used were in line or below comparable average growth for these measures in future years based on your long-term forecast.Rest of the question
You also state that considering these factors, you concluded the selected WACC, market multiples, long-term growth rate estimated fair value and indicated control premium were all reasonable. Please expand on these points and explain further how you concluded that the NA Business growth rates used were reasonable including more details about the comparisons referenced. In this regard, tell us whether you compared these amounts and/or rates with peers and, if so, tell us what the range of peers was and explain where you were within the range.
In Table A below, the selected LTGR of 0.25% for our NA Business reporting unit is shown in comparison to our key growth metrics in the final two years of our internal long-term forecast. Additionally, management compared Lumen to publicly available peer group metrics in the intermediate term (2022-2024) across our key metrics including revenue growth, Adjusted EBITDA growth and Adjusted EBITDA margin, as shown in Table B below. Lumen NA Business average revenue growth and Adjusted EBITDA growth and Adjusted EBITDA margin are all towards the bottom of the range.Read in the replyRest of the answer
As part of the forecast process, management goes beyond Lumen’s direct peers and also analyzed available industry data on channel and product trends in relation to our Lumen forecast, specifically focusing on NA Business Enterprise and Wholesale channel product trends within the context of Lumen’s historical performance and in combination with our revenue initiatives and go-to-market approach.
Table A
Revenue CAGR (last 2 years) EBITDA CAGR (last 2 years) Unlevered
Cash Flow
CAGR Unlevered
(last 2 year average) Revenue
(last 2 year average) Selected LTGR
NA Business 1.29% 3.97% 7.91% 4.99% 1.29% 0.25%
Table B
(Figures in Millions and Local Currency) Revenue Growth Adjusted EBITDA Growth Adjusted EBITDA Margin
Ticker Company CY2022 CY2023 CY2024 CY2022 CY2023 CY2024 CY2022 CY2023 CY2024
LUMN Lumen Technologies, Inc. -15.7% -15.4% -1.8% -19.5% -20.9% -0.8% 39.0% 36.4% 36.8%
T AT&T Inc. -25.9% -1.7% 1.5% -26.3% 2.0% 3.4% 33.4% 34.7% 35.4%
VZ Verizon Communications Inc. 2.4% 1.5% 1.6% 6.0% 1.7% 1.8% 35.1% 35.2% 35.2%
ATUS Altice USA, Inc. -3.8% -2.9% -1.1% -10.1% -3.3% 2.2% 40.1% 39.9% 41.3%
CHTR Charter Communications, Inc. 4.6% 2.0% 2.6% 5.5% 2.6% 4.3% 40.0% 40.2% 40.9%
CMCSA Comcast Corporation 4.3% -0.6% 2.2% 6.7% 0.4% 3.4% 30.4% 30.7% 31.1%
AKAM Akamai Technologies, Inc. 3.8% 4.6% 8.7% 27.6% 3.4% 10.5% 42.4% 41.9% 42.6%
BCE BCE Inc. 2.9% 2.8% 2.8% 23.4% 3.7% 3.7% 42.6% 43.0% 43.3%
Peer Average -1.7% 0.8% 2.6% 4.7% 1.5% 4.2% 37.7% 38.0% 38.5%
Peer statistics:
Minimum -25.9% -2.9% -1.1% -26.3% -3.3% 1.8% 30.4% 30.7% 31.1%
Average -1.7% 0.8% 2.6% 4.7% 1.5% 4.2% 37.7% 38.0% 38.5%
Median 2.9% 1.5% 2.2% 6.0% 2.0% 3.4% 40.0% 39.9% 40.9%
Maximum 4.6% 4.6% 8.7% 27.6% 3.7% 10.5% 42.6% 43.0% 43.3%
Table Notes:
- Lumen includes all Lumen reporting units and is impacted by divestitures completed during 2022. NA Business accounts for approximately 75% of Total Lumen revenue.
- Removing the impacts of the 20-state ILEC business divestiture completed October 3, 2022, estimated Lumen NA Business revenue growth and Adjusted EBITDA growth are -2.5% and -6.1%, respectively, on average over the period from 2022 through 2024, while average Adjusted EBITDA margin over the same period is approximately 32%; each of these metrics is below the corresponding peer average.
In connection with determining our LTGR, we review key metrics and multiples used to prepare our publicly available guidance and long-term forecast, as well as reviewing performance data of our peers and the broader industry for additional context. As noted in our prior reports, we expect capital investments and cost reduction initiatives being made in the near-term to drive improved long-term NA Business performance beginning in 2025. We assessed all of these factors in connection with determining that our LTGR is 0.25%.
Please tell us whether a sensitivity analysis was performed specific to the assumptions of revenue, adjusted EBITDA and unlevered cash flow growth rates, as well as the WACC, for the NA Business and if so, what those results were. Also, describe the trends in the NA Business assumptions over the last several years.
Lumen’s forecast process is a detailed, drivers-based model that uses hundreds of inputs to derive the forecast. Due to the complex nature of our forecasting process and the large number of metrics that are modeled, the process does not lend itself to simple sensitivity analysis. We do, however, run concurrent sensitivities around specific revenue and cost initiatives factoring in historical attainment.Read in the reply
As part of the forecasting process, hundreds of inputs are carefully considered and selected to arrive at the most-likely base forecast for Lumen, its reporting units, and certain key metricsRest of the answer
including revenue, Adjusted EBITDA and unlevered cash flow. Inputs, and their resulting impact to financial projections, are tested during the forecast update process and selected based on reasonableness. Input examples for NA Business include, but are not limited to:
•Sales bookings by month by sales channel based on number of sellers and average productivity per seller
•Revenue installation intervals and installed revenue values in relation to trailing sales levels
•Revenue disconnect rate % by month by sales channel
•Seasonal usage growth or decline rate by month by sales channel
•Certain direct costs (and direct margin) by product by sales channel that are associated with the provision of services and products to customers
•Operating expense by account and by department by month based on annual growth rates, sequential trends, % of revenue and other factors such as changes in headcount, average cost per headcount per department, increases in compensation and rent, capitalization rates by dept and seasonal variability (including utility costs and payroll taxes).
•Capital expenditures by program, details by capital type (Success Based, Project, Base and capitalized operating expense), and review as a % of annualized sales/installations, and as a % of revenue. We also include investments to support initiatives/optimization and other spending to support network capacity requirements and unit growth.
Our current year forecast for NA Business and other reporting units aligns to our external company guidance. The forecast process frequency is at minimum quarterly and typically multiple times per quarter. The long-range forecast is reviewed by Lumen’s Board of Directors annually and throughout the year in connection with assessing strategic alternatives, potential mergers and acquisitions, or divestitures.
Internal controls are in place to assure the inputs and resulting forecast output metrics fall within expected ranges based on historical company results, with a process to ensure any metrics falling outside of reasonable range thresholds are explainable as outlier events or are the result of intentional shifts in company strategy. Key metric ranges reviewed as part of internal controls include, but are not limited to:
•Quarterly revenue growth % by reporting unit
•Direct margin by reporting unit
•Direct cost as a % of revenue
•Net operating expense as a % of revenue
•Capital expenditures as a % of revenue
•Seasonal timing of net operating expense
•Changes in working capital
Sensitivities of company specific risk premiums on the WACC were considered ranging from approximately 0% to 8%.
NA Business WACC and LTGR are provided in the table below.
NA Business WACC 9.44% 7.44% 6.08% 7.60% 6.32% N/A
NA Business LTGR 0.25% 0.25% -0.66% -0.66% -0.62% N/A
(1) As previously disclosed, we made changes to our segment and customer-facing sales channel reporting categories in early 2021 to align with operational changes designed to better support our customers. Therefore, the NA Business WACC and LTGR were calculated using a weighted average of our previous reporting units in this trend analysis.
(2) Because our low share price was a trigger for impairment testing, we estimated the fair value of our operations using only the market approach.
Table Note: Please refer to the table in Response 2 above for the NA Business historical revenue and EBITDA multiples trends.
Based upon the forecast process and controls detailed above, management determined the NA Business segment Revenue, Adjusted EBITDA, Unlevered Cash Flow and WACC used to value the NA Business reporting unit were reasonable and appropriately considered key sensitivities and value drivers within the context of our historical performance, our position in the market, and our current strategic approach.
In your response, you indicate that one of the factors from which you determined that the 59% control premium was reasonable was that it was within the 1.3%-71.6% range of eleven transactions occurring between November 1, 2021 and October 31, 2022. Please provide us with more information regarding these eleven premiums, such as what they were individually or on a weighted average basis.Rest of the question
Further, describe the trends in your control premium over the last several years and explain any significant changes.
Consistent with each quantitative impairment analysis, we reviewed individual transactions in the telecommunications services sector that were announced or closed one year prior to our test date. Control premiums were paid on eleven transactions during the period November 1, 2021 and October 31, 2022. The control premium from our goodwill impairment test was within the range of the eleven transactions. The Company triangulates its WACC, LTGR and market multiples to derive a control premium that is in the range of comparable market transactions.Read in the replyRest of the answer
For October 2022, the Company also considered the EBITDA multiples of our recently closed Latin America Business and ILEC Business transactions resulting in a control premium that was at the higher end but still within the range of the eleven additional public transactions, which are listed in Table A below. Note that the March 2019 control premium of 4% was used to align the valuation to our current equity value by using only the market multiple approach, as the driving factor for the test completed in 1Q19 was a sustained decline in our share price.
Table B below provides the trends in our control premium over the last several years. Each year the Company applied a consistent methodology to conclude our control premium is reasonable based on prior market transactions applicable to such period, as well as other current market conditions.
Transaction(1)
Date Control Premium
#1 3/15/2022 58.7
#2 1/27/2022 10.6
#3 1/17/2022 9.6
#4 1/12/2022 1.3
#5 11/25/2021 1.9
#6 11/22/2021 7.0
#7 7/27/2022 4.1
#8 5/14/2022 10.4
#9 3/2/2022 21.5
#10 2/25/2022 3.9
#11 12/9/2021 71.6
(1) Source of transaction detail is S&P Capital IQ.
We note your response to prior comment 5. Please explain further how the significant decline in the company’s market capitalization throughout the last seven months (e.g. $7.6 billion as of October 31, 2022; $5.2 billion as of December 31, 2022; $2.4 billion as of April 5, 2023; and $2.3 billion as of May 2, 2023) did not trigger the need to perform a quantitative analysis; particularly given that the decline inRest of the question
market capitalization would presumably result in a much higher control premium that is outside the peer range. Further, please tell us whether you intend to perform a quantitative analysis in the quarter ended June 30, 2023. Notes to Consolidated Financial Statements (11) Segment Information, page 29
For the periods ended December 31, 2022 and March 31, 2023, the Company performed qualitative assessments of the facts and circumstances at each period end and concluded the Company did not have a goodwill impairment trigger. During these periods, the Company determined that recent near-term periods of growth or declines would normalize over time and moderate beyond the forecast horizon. The Company further determined that cost efficiencies and strategic investments made in the near-term would positively impact our future financial performance.Read in the replyRest of the answer
We also considered changes in our go-to-market strategies, sales channels, leadership changes and product categories (including our recent change to “growth/harvest/nurture/other” product categories) for each reporting unit and the areas where these initiatives would have the greatest impact on our forecasts, while considering each reporting unit’s respective strategic position, overall macroeconomic environment and related recessionary concerns. With respect to the Q4 2022 and Q1 2023 periods, we concluded that the share price decline was only one factor in considering whether we had a triggering event and that the price decline was most likely temporary based on our view that the benefits of our new strategies and leadership team announced in late 2022 and early 2023 would in the near-term be reflected in improvements in our share price. In addition, during Q1 2023, we compared our share price decline to the share price performance of our peers, and determined that over half of our peers had also experienced price declines. However, during Q2 2023 we reassessed prevailing conditions and market sentiments, and determined our share price will likely remain depressed until such time as investors perceive that our new strategies are working. Consequently, due to the sustained erosion of our market capitalization during Q2 2023, we believe a trigger for a quantitative goodwill impairment analysis has occurred. We have further determined our current market capitalization currently cannot be reconciled to a control premium based on recent market transactions. Therefore, we intend to perform a quantitative assessment as of May 31, 2023 weighting the market approach 100%, consistent with our 2019 first quarter impairment assessment. In connection with this assessment, we plan to compare the estimated fair value of our reporting units to our consolidated market value as of May 31, 2023.
Notes to Consolidated Financial Statements
(11) Segment Information, page 29
We note your response to prior comment 7 and the revised disclosures here continue to include Total Adjusted EBITDA. As previously indicated, this is a non-GAAP measure and is prohibited in the notes to the financial statements. Accordingly, please revise to remove both tables on page 30.Rest of the question
Further, we note that you removed the reconciliation of the total segments' measure of profit or loss to consolidated net income, which is required by ASC 280-10-50-30b. Therefore, revise to include the reconciliation from total segment adjusted EBITDA to net (loss) income, consistent with the reconciliation included on page 133 in the Form 10-K for the year ended December 31, 2022.
The Company confirms that in future filings, including the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, the Company will remove both tables on Page 30 of the Form 10-Q for the Quarterly Period Ended March 31, 2023. Additionally, the Company will revise the reconciliation table of total segment’s measure of profit or loss to consolidated net income as required in ASC 280-10-50-30b. Please see Appendix 1 to this letter.Read in the reply
We note your response to prior comment 10 and revised presentation here. Please further revise to present Net Income, the most directly comparable GAAP measure to Adjusted EBITDA and Adjusted EBITDA, Excluding Special Items, and Net Income margin, the most directly comparable GAAP measure to Adjusted EBITDA Margin and Adjusted EBITDA Margin, Excluding Special Items, with greater prominence than the respectiveRest of the question
non-GAAP measures. Similar concerns apply to the presentation on page 3. In this regard, we note that you present Adjusted EBITDA, Excluding Specials Items and the respective margin without presenting the GAAP measure more prominently. Also, revise to remove the "Operating income" line in the reconciliation from net income to adjusted EBITDA on page 16. Refer to Question 103.02 of the Non-GAAP C&DIs.
The Company confirms that in future filings, including the Company’s earnings release for the quarter ended June 30, 2023, the Company will provide Net Income as the most directly comparable GAAP measure. Further, the Company will present Net Income (Loss) and Net Income (Loss) Margin with greater prominence before Adjusted EBITDA and Adjusted EBITDA margin in the recurring Financial Results table.Read in the replyRest of the answer
The Company also confirms that “Operating Income” will be removed from the reconciliation of Net Income to Adjusted EBITDA in future filings, including the Company’s earnings release for the quarter ended June 30, 2023, in accordance with Question 103.02 of the Non-GAAP C&DIs. Please see Appendix 2 to this letter.
The Company acknowledges that the Company and its management are responsible for the accuracy and adequacy of the disclosure, notwithstanding any review, comments, action, or absence of action by the Staff. The Company qualifies each of its forward-looking statements contained in this letter by reference to the qualifying factors and risk factor disclosures contained in its filings with the SEC.
First report after the company's reply of Jun 12, 2023: 10-Q filed Aug 1, 2023 ↗, against the 10-Q filed Nov 3, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2023-08-08